Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06610448 · ClinicalTrials.gov registry record · NA
Wearable Evaluation of Ambulatory Readings for Blood Pressure
A NA study of Uncontrolled Hypertension and Normal Blood Pressure, sponsored by Stephen Juraschek.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06610448: Recruiting NA study of Uncontrolled Hypertension and Normal Blood Pressure, sponsored by Stephen Juraschek.
NCT06610448 is a NA study of Uncontrolled Hypertension and Normal Blood Pressure that is actively recruiting participants, run by Stephen Juraschek. The registered enrollment target is 100 participants, below the 754-participant average among 10 other Uncontrolled Hypertension trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06610448, a NA study of Uncontrolled Hypertension and Normal Blood Pressure, is actively recruiting participants, sponsored by Stephen Juraschek.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to compare the performance and validity of novel wearable technologies that measure blood pressure (BP) and physical activity with a Spacelabs Ambulatory Blood Pressure Monitoring (ABPM) device.
Primary Outcome
Measured from all 5 randomized devices
Conditions Studied
Interventions
- DEVICE ABPMPro
- DEVICE Spacelabs Ambulatory Blood Pressure Monitoring
- DEVICE Aktiia Blood Pressure
- DEVICE LiveMetric
- DEVICE Bpro
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-06-06 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06610448 shows while recruiting
NCT06610448 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 754-participant average among 10 other Uncontrolled Hypertension trials with a reported enrollment target (87% lower).
The record links to 3 conditions, with Uncontrolled Hypertension appearing as the primary indexed condition, and to 5 interventions - of which ABPMPro is the first listed.
NCT06610448 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06610448 about?
NCT06610448 is a clinical study titled "Wearable Evaluation of Ambulatory Readings for Blood Pressure". The purpose of this project is to compare the performance and validity of novel wearable technologies that measure blood pressure (BP) and physical activity with a Spacelabs Ambulatory Blood Pressure Monitoring (ABPM) device.
What is the current status of trial NCT06610448?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-06-06. Estimated completion is 2026-06-30.
What conditions does trial NCT06610448 study?
This clinical trial studies the following conditions: Uncontrolled Hypertension, Normal Blood Pressure, Controlled Hypertension.
What interventions are being tested in trial NCT06610448?
The interventions under investigation include: ABPMPro (DEVICE), Spacelabs Ambulatory Blood Pressure Monitoring (DEVICE), Aktiia Blood Pressure (DEVICE), LiveMetric (DEVICE), Bpro (DEVICE).
Who is sponsoring clinical trial NCT06610448?
This trial is sponsored by Stephen Juraschek, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06610448 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uncontrolled Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06610448's enrollment target sits among peer trials
100 8th of 10 higher than 3 of 10 other Uncontrolled Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Uncontrolled Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity
RECRUITING · NA
-
Renal Pelvic Denervation Pilot Trial
RECRUITING · NA
-
Remote Hypertension Management for Black Patients
RECRUITING · NA
-
Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes.
ACTIVE NOT RECRUITING · NA
-
Technology Coaching Intervention for Black Women With Hypertension
COMPLETED · NA
-
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI